oxytocin [Ligand Id: 2174] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL395429 (Alpha-hypophamine, Endopituitrina, Intertocine s, Orasthin, Oxytocin, Oxytocinum, Pitocin, Syntocinon, Syntometrine, TNX-1900, TNX1900, TTA-121) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| OT receptor/Oxytocin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2049] [GtoPdb: 369] [UniProtKB: P30559] | ||||||||
| ChEMBL | Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor | B | 8.17 | pKd | 6.7 | nM | Kd | Bioorg Med Chem Lett (1999) 9: 667-672 [PMID:10201826] |
| ChEMBL | Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane | B | 8.17 | pKd | 6.7 | nM | Kd | J Med Chem (1994) 37: 255-259 [PMID:7507528] |
| ChEMBL | Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate | B | 8.02 | pKi | 9.53 | nM | Ki | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| ChEMBL | Binding affinity to oxytocin receptor | B | 8.17 | pKi | 6.8 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 990-994 [PMID:19095447] |
| ChEMBL | Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate | B | 8.18 | pKi | 6.6 | nM | Ki | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| ChEMBL | Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method | B | 8.92 | pKi | 1.2 | nM | Ki | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| ChEMBL | Binding affinity for human oxytocin receptor | B | 9.1 | pKi | 0.8 | nM | Ki | J Med Chem (2002) 45: 2579-2588 [PMID:12036367] |
| ChEMBL | Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis | B | 9.1 | pKi | 0.8 | nM | Ki | Eur J Med Chem (2016) 108: 730-740 [PMID:26741855] |
| ChEMBL | Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assay | B | 9.1 | pKi | 0.79 | nM | Ki | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| ChEMBL | Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells | B | 9.1 | pKi | 0.79 | nM | Ki | J Med Chem (2010) 53: 8585-8596 [PMID:21117646] |
| ChEMBL | Binding affinity to OTR (unknown origin) | B | 9.1 | pKi | 0.79 | nM | Ki | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| ChEMBL | Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr | B | 9.24 | pKi | 0.58 | nM | Ki | J Med Chem (2019) 62: 3297-3310 [PMID:30896946] |
| ChEMBL | Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method | B | 9.36 | pKi | 0.44 | nM | Ki | Bioorg Med Chem (2016) 24: 3513-3520 [PMID:27297999] |
| GtoPdb | - | - | 9.6 | pKi | - | - | - |
Br J Obstet Gynaecol (1999) 106: 1047-53 [PMID:10519430]; EMBO J (1995) 14: 2176-82 [PMID:7774575]; J Pharmacol Exp Ther (2003) 306: 253-61 [PMID:12660315]; Br J Pharmacol (2005) 146: 744-751 [PMID:16158071]; Life Sci (1995) 57: 2253-61 [PMID:7475979]; FEBS Lett (1996) 397: 201-6 [PMID:8955347] |
| ChEMBL | Displacement of [3H]OT from human OT receptor expressed in HEK cells | B | 8.57 | pIC50 | 2.7 | nM | IC50 | Eur J Med Chem (2007) 42: 799-806 [PMID:17316912] |
| ChEMBL | Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay | F | 7.59 | pEC50 | 26 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| ChEMBL | Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay | B | 7.82 | pEC50 | 15 | nM | EC50 | J Med Chem (2010) 53: 8585-8596 [PMID:21117646] |
| ChEMBL | Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay | F | 7.97 | pEC50 | 10.8 | nM | EC50 | J Med Chem (2011) 54: 2864-2877 [PMID:21428295] |
| ChEMBL | Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay | B | 8.05 | pEC50 | 9 | nM | EC50 | Bioorg Med Chem Lett (2017) 27: 2331-2335 [PMID:28438540] |
| ChEMBL | Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay | F | 8.1 | pEC50 | 8 | nM | EC50 | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| ChEMBL | Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay | F | 8.3 | pEC50 | 5 | nM | EC50 | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| ChEMBL | Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay | F | 8.52 | pEC50 | 3 | nM | EC50 | Eur J Med Chem (2016) 108: 730-740 [PMID:26741855] |
| ChEMBL | Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay | B | 8.64 | pEC50 | 2.3 | nM | EC50 | J Med Chem (2014) 57: 5306-5317 [PMID:24874785] |
| ChEMBL | Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay | B | 8.64 | pEC50 | 2.29 | nM | EC50 | J Med Chem (2020) 63: 382-390 [PMID:31850759] |
| ChEMBL | Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay | B | 8.68 | pEC50 | 2.1 | nM | EC50 | J Med Chem (2016) 59: 7152-7166 [PMID:27420737] |
| ChEMBL | Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay | B | 8.89 | pEC50 | 1.28 | nM | EC50 | J Med Chem (2020) 63: 382-390 [PMID:31850759] |
| ChEMBL | Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay | F | 9.15 | pEC50 | 0.7 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| ChEMBL | Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay | F | 9.52 | pEC50 | 0.3 | nM | EC50 | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| ChEMBL | Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay | F | 10.4 | pEC50 | 0.04 | nM | EC50 | Bioorg Med Chem Lett (2018) 28: 415-419 [PMID:29273395] |
| ChEMBL | Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay | F | 10.4 | pEC50 | 0.04 | nM | EC50 | Bioorg Med Chem (2016) 24: 3513-3520 [PMID:27297999] |
| ChEMBL | Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method | F | 11 | pEC50 | 0.01 | nM | EC50 | J Med Chem (2019) 62: 3297-3310 [PMID:30896946] |
| OT receptor/Oxytocin receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3243907] [GtoPdb: 369] [UniProtKB: P97926] | ||||||||
| ChEMBL | Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay | F | 8.7 | pEC50 | 2 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| OT receptor/Oxytocin receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3996] [GtoPdb: 369] [UniProtKB: P70536] | ||||||||
| GtoPdb | - | - | 8.7 | pKi | - | - | - | J Pharmacol Exp Ther (2003) 306: 253-61 [PMID:12660315] |
| ChEMBL | Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin | B | 8.77 | pKi | 1.7 | nM | Ki | J Med Chem (1997) 40: 864-876 [PMID:9083475] |
| ChEMBL | Binding affinity against oxytocin receptor in rat uterus | B | 9.05 | pKi | 0.89 | nM | Ki | J Med Chem (1990) 33: 2321-2323 [PMID:2167976] |
| V1A receptor/Vasopressin V1a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288] | ||||||||
| ChEMBL | Binding affinity for human Vasopressin V1a receptor | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2002) 45: 2579-2588 [PMID:12036367] |
| ChEMBL | Binding affinity to V1aR (unknown origin) | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| ChEMBL | Binding affinity to vasopressin V1a receptor | B | 7.46 | pKi | 34.9 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 990-994 [PMID:19095447] |
| ChEMBL | Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method | B | 7.7 | pKi | 20 | nM | Ki | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| GtoPdb | - | - | 8.3 | pKi | - | - | - |
J Biol Chem (1994) 269: 3304-10 [PMID:8106369]; J Biol Chem (1997) 272: 26536-44 [PMID:9334232]; Br J Pharmacol (1998) 125: 1463-70 [PMID:9884074]; Endocrinology (1997) 138: 4109-22 [PMID:9322919]; Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 63-9 [PMID:9459574]; Biochem Pharmacol (1997) 53: 1711-1717 [PMID:9264324]; J Pharmacol Exp Ther (2003) 306: 253-61 [PMID:12660315]; Br J Obstet Gynaecol (1999) 106: 1047-53 [PMID:10519430] |
| ChEMBL | Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2014) 57: 5306-5317 [PMID:24874785] |
| ChEMBL | Agonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay | F | 6.59 | pEC50 | 260 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| ChEMBL | Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | B | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (2014) 57: 5306-5317 [PMID:24874785] |
| ChEMBL | Agonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay | F | 8.05 | pEC50 | 9 | nM | EC50 | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| ChEMBL | Agonist activity at vasopressin 1a receptor (unknown origin) | F | 8.11 | pEC50 | 7.7 | nM | EC50 | Bioorg Med Chem Lett (2018) 28: 415-419 [PMID:29273395] |
| ChEMBL | Agonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method | F | 9.74 | pEC50 | 0.18 | nM | EC50 | Bioorg Med Chem (2019) 27: 3358-3363 [PMID:31229420] |
| V1A receptor in Rat [GtoPdb: 366] [UniProtKB: P30560] | ||||||||
| GtoPdb | - | - | 6.1 | pKi | - | - | - | EMBO J (1995) 14: 2176-82 [PMID:7774575] |
| V1B receptor/Vasopressin V1b receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1921] [GtoPdb: 367] [UniProtKB: P47901] | ||||||||
| ChEMBL | Displacement of [3H]AVP from human vasopressin V1b receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method | B | 5.22 | pKi | >6000 | nM | Ki | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| ChEMBL | Binding affinity to V1bR (unknown origin) | B | 5.75 | pKi | 1782 | nM | Ki | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| GtoPdb | - | - | 7 | pKi | - | - | - |
Br J Pharmacol (1998) 125: 1463-70 [PMID:9884074]; Endocrinology (1997) 138: 4109-22 [PMID:9322919]; Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 63-9 [PMID:9459574]; Biochem Pharmacol (1997) 53: 1711-1717 [PMID:9264324]; Br J Pharmacol (2005) 146: 744-751 [PMID:16158071] |
| ChEMBL | Agonist activity at human vasopressin V1b expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | B | 6.62 | pEC50 | 240 | nM | EC50 | J Med Chem (2014) 57: 5306-5317 [PMID:24874785] |
| ChEMBL | Agonist activity at human V1b receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay | F | 7.41 | pEC50 | 39 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| ChEMBL | Agonist activity at human vasopressin V1b receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay | F | 7.48 | pEC50 | 33 | nM | EC50 | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| ChEMBL | Agonist activity at human V1b receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay | F | 7.54 | pEC50 | 29 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| ChEMBL | Agonist activity at human vasopressin V1b receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay | F | 7.61 | pEC50 | 24.5 | nM | EC50 | J Med Chem (2011) 54: 2864-2877 [PMID:21428295] |
| ChEMBL | Agonist activity at human V1B receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method | F | 9.7 | pEC50 | 0.2 | nM | EC50 | Bioorg Med Chem (2019) 27: 3358-3363 [PMID:31229420] |
| V2 receptor/Vasopressin V2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1790] [GtoPdb: 368] [UniProtKB: P30518] | ||||||||
| ChEMBL | Displacement of [3H]AVP from human kidney vasopressin V2 receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method | B | 5.22 | pKi | >6000 | nM | Ki | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| ChEMBL | Binding affinity towards human Vasopressin V2 receptor | B | 5.46 | pKi | 3500 | nM | Ki | J Med Chem (2002) 45: 2579-2588 [PMID:12036367] |
| ChEMBL | Binding affinity to V2R (unknown origin) | B | 5.81 | pKi | 1544 | nM | Ki | J Med Chem (2015) 58: 2547-2552 [PMID:25642985] |
| GtoPdb | - | - | 6.8 | pKi | - | - | - |
Br J Pharmacol (1998) 125: 1463-70 [PMID:9884074]; Endocrinology (1997) 138: 4109-22 [PMID:9322919]; Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 63-9 [PMID:9459574]; Biochem Pharmacol (1997) 53: 1711-1717 [PMID:9264324]; EMBO J (1995) 14: 2176-82 [PMID:7774575]; J Pharmacol Exp Ther (2003) 306: 253-61 [PMID:12660315] |
| ChEMBL | Agonist activity at human V2 receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay | F | 6.09 | pEC50 | 810 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| ChEMBL | Agonist activity at human V2 receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay | F | 6.68 | pEC50 | 210 | nM | EC50 | J Med Chem (2018) 61: 8670-8692 [PMID:30199637] |
| ChEMBL | Agonist activity at human kidney vasopressin V2 receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay | F | 7.54 | pEC50 | 29 | nM | EC50 | Bioorg Med Chem (2018) 26: 3039-3045 [PMID:29602673] |
| ChEMBL | Agonist activity at human vasopressin V2 expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay | B | 8.14 | pEC50 | 7.3 | nM | EC50 | J Med Chem (2014) 57: 5306-5317 [PMID:24874785] |
| V2 receptor/Vasopressin V2 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3766] [GtoPdb: 368] [UniProtKB: Q00788] | ||||||||
| ChEMBL | Binding affinity against Vasopressin receptor in rat kidney medulla | B | 7.06 | pKi | 88 | nM | Ki | J Med Chem (1990) 33: 2321-2323 [PMID:2167976] |
| ChEMBL | Binding affinity against Vasopressin receptor in rat liver | B | 7.21 | pKi | 61 | nM | Ki | J Med Chem (1990) 33: 2321-2323 [PMID:2167976] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
